Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoricoxib/Betamethasone FDC vs Etoricoxib in Acute Gouty Arthritis
NCT06863701Phase 3Recruiting
- Sponsor
- Laboratorios Silanes
- Start
- Jan 2025
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of etoricoxib, betamethasone in acute gouty arthritis, sponsored by Laboratorios Silanes. Started Jan 2025; status: recruiting.
02
Drugs
etoricoxibbetamethasone
03
Conditions
acute gouty arthritis
Beyond the preview
Go deeper on NCT06863701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06863701.